Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate a systematic review and meta-analysis

Obstetrical and Gynecological Survey

Volumn 63, Issue 7, 2008, Pages 472-479

  Polyzos, Nikolaos P ^a   Tzioras, Spyridon ^a   Mauri, Davide ^b   Tsappi, Maria ^b   Cortinovis, Ivan ^c   Tsali, Lamprini ^b   Casazza, Giovanni ^c  

^a Panhellenic Association for Continual Medical Research PACMeR   (Greece)

^b Panhellenic Association for Continual Medical Research   (Greece)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE CITRATE; LETROZOLE; CLOMIFENE; FERTILITY PROMOTING AGENT;

CLINICAL TRIAL; COCHRANE LIBRARY; FEMALE INFERTILITY; HUMAN; MEDLINE; META ANALYSIS; OVULATION; PREGNANCY RATE; REVIEW; SYSTEMATIC REVIEW; ADULT; FEMALE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RISK;

ADULT; AROMATASE INHIBITORS; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; ODDS RATIO; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 55449121966     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31817d4e8d     Document Type: Review

References (31)

1. Collins J. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Current best evidence for the advanced treatment of unexplained subfertility. Hum Reprod 2003;18:907-912.
2. Dankert T, Kremer JA, Cohlen BJ, et al. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod 2007; 22:792-797.
3. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev 2000;3:CD000057.
4. SchenkerJG,YarkoniS,GranatM. Multiplepregnanciesfollowinginductionofovulation.FertilSteril1981;35:105-123. (Pubitemid11137709)
5. Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2006;91:760-771.
6. Mauri D, Pavlidis N, Polyzos NP, et al. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst 2006;98:1285-1291. (Pubitemid 44530724)
7. Polyzos NP, Tsappi M, Mauri D, et al. Aromatase inhibitors for infertility in the polycystic ovary syndrome. The beginning or the end of a new era? Fertil Steril 2008;89:278-280.
8. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85: 1761-1765. (Pubitemid 43816444)
9. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 2006;61:125-135. (Pubitemid 43361646)
10. The Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook; 2007. Available at: http://www.cochrane.org/resources/handbook/ handbook.pdf Accessed January 18, 2007.
11. Egger M, Davey Smith G, Altman DG, eds. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd ed. London: BMJ Books; 2001.
12. Al-Fozan H, Al-Khadouri M, Tan SL, et al. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004;82:1561-1563. (Pubitemid 39611383)
13. Barroso G, Menocal G, Felix H, et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial. Fertil Steril 2006;86:1428-1431. (Pubitemid 44602032)
14. FatemiHM,KoliblanakisE,TournayeH,etal. Clomiphenecitrateversusletrozoleforovarianstimulation:apilotstudy. ReprodBiomedOnline2003;7:543-546.(Pubitemid37455975)
15. Sipe CS, Davis WA, Maifeld M, et al. A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins. Fertil Steril 2006;86:1676-1681. (Pubitemid 44778736)
16. Wu HH, Wang NM, Cheng ML, et al. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility. Gynecol Endocrinol 2007; 23:76-81.
17. Bayar U, Tanriverdi HA, Barut A, et al. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril 2006;85:1045-1048.
18. Badawy A, Metwally M, Fawzy M. Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility. Reprod Biomed Online 2007;14: 559-562.
19. Al-Fadhli R, Sylvestre C, Buckett W, et al. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 2006;85:161-164.
20. Al-Omari WR, Sulaiman WR, Al-Hadithl N. Comparison of two aromatase inhibitors in women with clomiphene-reslstant polycystic ovary syndrome. Int J Gynaecol Obstet 2004;85: 289-291.
21. Badawy A, Mosbah A, Shady M. Anastrozole or letrozole for ovulation induction in clomiphene-reslstant women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2007: Epub ahead of print.
22. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with 609 estimates of treatment effects in controlled trials. JAMA 1995;273:408-412.
23. JuniP,AltmanDG,EggerM.Systematicreviewsinhealthcare: assessingthequalityofcontrolledclinicaltrials.BMJ2001;323:42-46. (Pubitemid32682008)
24. Ioannidis JP, Lau J. Can quality of clinical trials and metaanalyses be quantified? Lancet 1998;352:590-591.
25. BalkEM,BonisPA,MoskowitzH,etal. Correlationofqualitymeasureswithestimatesoftreatmenteffectinmeta- analysesofrandomizedcontrolledtrials.JAMA2002;287:2973-2982.(Pubitemid34620001)
26. Deaton JL, Gibson M, Blackmer KM, et al. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990;54:1083-1088.
27. GonenY,CasperRF. Sonographicdeterminationofapossibleadverseeffectofclomiphenecitrateonendom etrialgrowth.HumReprod1990;5:670-674.(Pubitemid20308440)
28. Goverde AJ, McDonnell J, Vermeiden JP, et al. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-18. (Pubitemid 30072177)
29. Bedaiwy MA, Forman R, Mousa NA, et al. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Hum Reprod 2006;21:2838-2844. (Pubitemid 44566995)
30. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005;84(suppl 1):0-231, Abstract 1033.
31. Fontana PG, Leclerc JM. Contraindication of Femara®(letrozole) in premenopausal women. Available at: http://www.ca.novartis.com/downloads/en/ letters/femara-hcp-e-17-11-05.pdf.